<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
61434-004-00
</NDCCode>
<PackageDescription>
800 SYRINGE in 1 CASE (61434-004-00) / .8 mL in 1 SYRINGE
</PackageDescription>
<NDC11Code>
61434-0004-00
</NDC11Code>
<ProductNDC>
61434-004
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Adalimumab-adbm
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20230701
</StartMarketingDate>
<EndMarketingDate>
20260506
</EndMarketingDate>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Catalent Indiana, LLC
</LabelerName>
<SubstanceName>
ADALIMUMAB-ADBM
</SubstanceName>
<StrengthNumber>
40
</StrengthNumber>
<StrengthUnit>
mg/.8mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-02-04
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage>
01-JUL-23
</StartMarketingDatePackage>
<EndMarketingDatePackage>
06-MAY-26
</EndMarketingDatePackage>
<SamplePackage/>
</NDC>